VHL - Von Hippel-Lindau syndrome

This test is available for the following conditions:

  • Conditions > Endocrine > Von Hippel-Lindau syndrome
  • Conditions > Renal / Nephrological > Von Hippel-Lindau syndrome
  • Conditions > Oncogenetics > Von Hippel-Lindau syndrome
  • Conditions > Vision impairment / blindness > Von Hippel-Lindau syndrome

This product is also part of the following panels:

  • panel hereditary renalcancer (SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, PTEN, FLCN, MET, FH, BAP1)
  • WES ciliopathies (% *)
  • WES comprehensive preconception carrier test ¹
  • WES hereditary cancer (% *)
  • WES Mendelian inherited disorders (% *)
  • WES skin disorders¹ (% *)
  • WES vision disorders (% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)

OMIM: 608537
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA, Buccal mucous membrane




€ 616

Gene

VHL - Von Hippel-Lindau syndrome

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 616

VHL - Von Hippel-Lindau syndrome



€ 616